Is cytokine removal by continuous hemofiltration feasible?

Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein

Charles J. Fisher, Jan M. Agosti, Steven M. Opal et al. · New England Journal of Medicine · 1996 · 1.2K citations

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

Charles J. Fisher · JAMA · 1994 · 932 citations

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis

Steven M. Opal, Charles J. Fisher, Jean-François Dhainaut et al. · Critical Care Medicine · 1997 · 856 citations

Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis Syndrome

Edward Abraham · JAMA · 1995 · 825 citations

Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome

Charles J. Fisher · JAMA · 1994 · 780 citations

Immunology, Receptor Antagonist, Pharmacotherapy +16